Cyxone AB (FRA:4CX) Other Long Term Assets : €0.03 Mil (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Cyxone AB Other Long Term Assets?

Cyxone AB's other long-term assets for the quarter that ended in Jun. 2024 was €0.03 Mil.

Cyxone AB's quarterly other long-term assets increased from Dec. 2023 (€0.03 Mil) to Mar. 2024 (€0.03 Mil) but then stayed the same from Mar. 2024 (€0.03 Mil) to Jun. 2024 (€0.03 Mil).

Cyxone AB's annual other long-term assets increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.03 Mil) and increased from Dec. 2022 (€0.03 Mil) to Dec. 2023 (€0.03 Mil).

Cyxone AB Other Long Term Assets Historical Data

The historical data trend for Cyxone AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyxone AB Other Long Term Assets Chart

Cyxone AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

0.03

Cyxone AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long Term Assets	Get a 7-Day Free Trial															0.03	0.03	0.03	0.03	0.03

Cyxone AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Cyxone AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyxone AB (FRA:4CX) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyllie Boulevard 34, Malmo, SWE, 215 32

Website

https://www.cyxone.com

Cyxone AB is a clinical biotech company with a portfolio of immunomodulating drugs for the treatment of autoimmune diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA). The product candidates of the company include T20K and Rabeximod.

Cyxone AB Headlines

No Headlines